VIKING THERAPEUTICS INC's ticker is VKTX and the CUSIP is 92686J106. A total of 186 filers reported holding VIKING THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.46 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $15,598 | -96.6% | 1,409 | -95.0% | 0.00% | -100.0% |
| Q2 2023 | $460,202 | -19.3% | 28,390 | -17.2% | 0.00% | 0.0% |
| Q1 2023 | $570,580 | +57.4% | 34,269 | -11.2% | 0.00% | 0.0% |
| Q4 2022 | $362,558 | +1150.2% | 38,570 | +727.3% | 0.00% | – |
| Q3 2021 | $29,000 | -3.3% | 4,662 | -5.9% | 0.00% | – |
| Q2 2021 | $30,000 | -6.2% | 4,953 | -1.0% | 0.00% | – |
| Q1 2021 | $32,000 | +300.0% | 5,002 | +242.8% | 0.00% | – |
| Q4 2020 | $8,000 | -65.2% | 1,459 | -62.8% | 0.00% | – |
| Q3 2020 | $23,000 | -23.3% | 3,925 | -5.1% | 0.00% | – |
| Q2 2020 | $30,000 | +50.0% | 4,135 | -2.5% | 0.00% | – |
| Q1 2020 | $20,000 | -37.5% | 4,243 | +5.2% | 0.00% | – |
| Q4 2019 | $32,000 | +18.5% | 4,033 | +1.2% | 0.00% | – |
| Q3 2019 | $27,000 | -20.6% | 3,987 | -2.6% | 0.00% | – |
| Q2 2019 | $34,000 | -17.1% | 4,095 | -1.3% | 0.00% | – |
| Q1 2019 | $41,000 | – | 4,151 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| APIS CAPITAL ADVISORS, LLC | 148,000 | $1,638,360 | 2.12% |
| Sio Capital Management, LLC | 595,002 | $6,586,672 | 2.04% |
| 5AM Venture Management, LLC | 585,000 | $6,475,950 | 1.86% |
| Artia Global Partners LP | 383,580 | $4,246,231 | 1.76% |
| Integral Health Asset Management, LLC | 800,000 | $8,856,000 | 1.23% |
| Boxer Capital, LLC | 2,000,000 | $22,140,000 | 1.18% |
| DAFNA Capital Management LLC | 319,655 | $3,538,581 | 1.10% |
| Affinity Asset Advisors, LLC | 332,600 | $3,681,882 | 1.04% |
| MPM BioImpact LLC | 325,000 | $3,597,750 | 0.96% |
| Affinity Asset Advisors, LLC | 300,000 | $3,321,000 | 0.93% |